all report title image

HUMIRA BIOSIMILAR MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Humira Biosimilar Market, By Product Type (Biosimilar Humira (Adalimumab), and Interchangeable Biosimilar Humira), By Indication (Rheumatoid Arthritis, Psoriasis, Crohns Disease, Ulcerative Colitis, Ankylosing Spondylitis, Juvenile Idiopathic Arthritis, and Other Autoimmune Conditions), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Patient Age (Adult Patients, Pediatric Patients, and Geriatric Patients), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

  • Published In: 26 Mar, 2026
  • Code: CMI5925
  • Page number: 155
  • Formats:   Excel and PDF
  • Industry: Biotechnology
    • Historical Range : 2020 - 2024
    • Base Year : 2025
    • Estimated Year : 2026
    • Forecast Period : 2026-2033
Ingographics Image

Table of Contents (Version-2026)

  1. Research Objectives and Assumptions

    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview

    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Product Type
      • Market Snippet, By Indication
      • Market Snippet, By Distribution Channel
      • Market Snippet, By Patient Age
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
      • Patent expiration
      • Cost savings
      • Increasing prevalence of autoimmune diseases
      • Favorable regulatory environment
    • Market Restraints
    • Market Opportunity
    • Key Highlights
    • Regulatory Scenario
    • Recent Trends
    • Product Launches/Approvals
    • PEST Analysis
    • PORTER’s Analysis
    • Mergers Acquisitions, and Collaborations
  4. Global Humira Biosimilar Market, By Product Type, 2021 - 2033, (USD Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 – 2033
      • Segment Trends
    • Biosimilar Humira (Adalimumab)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
    • Interchangeable Biosimilar Humira
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
  5. Global Humira Biosimilar Market, By Indication, 2021 - 2033, (USD Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 – 2033
      • Segment Trends
    • Rheumatoid Arthritis
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
    • Psoriasis
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
    • Crohn’s disease
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
    • Ulcerative Colitis
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
    • Ankylosing Spondylitis
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
    • Juvenile Idiopathic Arthritis
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
    • Other Autoimmune Conditions
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
  6. Global Humira Biosimilar Market, By Patient Age, 2021 - 2033, (USD Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 – 2033
      • Segment Trends
    • Adult Patients
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
    • Pediatric Patients
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
    • Geriatric Patients
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
  7. Global Humira Biosimilar Market, By Distribution Channel, 2021 - 2033, (USD Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 – 2033
      • Segment Trends
    • Hospital Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
    • Retail Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
    • Online Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
  8. Global Humira Biosimilar Market, By Region, 2021 - 2033, (USD Mn)

    • Introduction
      • Market Share Analysis, By Region, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, For Region, 2022 –2033
      • Country Trends
    • North America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Patient Age, 2021 - 2033, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
        • U.S.
        • Canada
    • Europe
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Patient Age, 2021 - 2033, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Patient Age, 2021 - 2033, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Patient Age, 2021 - 2033, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Middle East
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Patient Age, 2021 - 2033, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Patient Age, 2021 - 2033, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country/ Region, 2021 - 2033, (USD Mn)
        • North Africa
        • Central Africa
        • South Africa
  9. Competitive Landscape

    • Company Profiles
      • Amgen Inc.
        • Company Highlights
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Samsung Bioepis Co.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Sandoz International GmbH (Novartis AG)
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Mylan N.V.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Boehringer Ingelheim International GmbH
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Pfizer Inc.
        •  Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Fresenius Kabi AG
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Coherus BioSciences
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Biogen Inc.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • AbbVie Inc.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Celltrion Inc.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Rani Therapeutics Holdings, Inc.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Teva Pharmaceutical Industries Ltd.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Merck & Co.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Viatris Inc.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Alvotech
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Analysts’ Views
  10. Section

    • References
    • Research Methodology
    • About us
  • Need a Custom Report?

    We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

    Customize Now
Logo

Credibility and Certifications

DUNS Registered

860519526

ESOMAR
Credibility and Certification

9001:2015

Credibility and Certification

27001:2022

Clutch
Credibility and Certification

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo

© 2026 Coherent Market Insights Pvt Ltd. All Rights Reserved.